公司资料
Glaukos Corporation 股价、新闻与催化剂
- 股票代码:
- GKOS
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
161.42 USD (-1.25%)
收盘价
最后更新: 2026年9月17日
6.51B USD
市值
股价为何变动
截至 2026年9月17日，GKOS 下跌 1.25%，收于 $161.42。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Glaukos is a medical technology company focused on ophthalmology, glaucoma devices, and corneal health. Its business is centered on procedure-based eye-care technologies rather than therapeutics.
所在地与行业分类
Glaukos is headquartered in the United States and listed on NYSE. It sits in ophthalmic medtech rather than biotechnology.
商业模式特征
The company depends on device adoption, surgeon acceptance, and the ability to expand across eye-care procedures. Investors watch product launches, clinical adoption, and margin trends.
生物医药行业定位
Glaukos occupies a high-quality ophthalmic-device niche within healthcare innovation. It is not biotech, but it is a procedure-driven growth stock with meaningful clinical relevance.
未来催化剂
- Glaukos’s catalysts are iStent / iDose commercialization, glaucoma adoption, and continued procedural growth in ophthalmology. The market will care about whether the device base keeps broadening.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。